Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition
- 30 June 2005
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 26 (6) , 294-301
- https://doi.org/10.1016/j.tips.2005.04.006
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Proprotein Convertase Models based on the Crystal Structures of Furin and Kexin: Explanation of their SpecificityJournal of Molecular Biology, 2005
- β‐Amyloid protein converting enzyme 1 and brain‐specific type II membrane protein BRI3: binding partners processed by furinJournal of Neurochemistry, 2004
- Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirusBiochemical and Biophysical Research Communications, 2004
- Polyarginine Inhibits gp160 Processing by Furin and Suppresses Productive Human Immunodeficiency Virus Type 1 InfectionPublished by Elsevier ,2004
- Inhibition of furin by serpin Spn4A from Drosophila melanogasterFEBS Letters, 2004
- Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptorBiochemical and Biophysical Research Communications, 2004
- DrosophilaSerpin 4 Functions as a Neuroserpin-Like Inhibitor of Subtilisin-Like Proprotein ConvertasesJournal of Neuroscience, 2004
- The Furin Inhibitor Hexa-d-Arginine Blocks the Activation ofPseudomonas aeruginosaExotoxin A In VivoInfection and Immunity, 2002
- Furin at the cutting edge: From protein traffic to embryogenesis and diseaseNature Reviews Molecular Cell Biology, 2002
- On the active site of proteases. III. Mapping the active site of papain; specific peptide inhibitors of papainBiochemical and Biophysical Research Communications, 1968